'Uncategorized' Category
By Simmons Hanly Conroy | July 16, 2014
American Medical Systems Enrolls First Patient in its Largest TVM Study to Date
American Medical Systems (AMS), a subsidiary of Endo International, enrolled the first patient in its mandatory post market surveillance study for the Elevate™ Anterior and Apical Prolapse Repair System. The study is… Read More
By Simmons Hanly Conroy | July 14, 2014
New FDA Warning Against Use of Numbing Medications in Infants
Parents with teething infants should not use “gum-numbing” anesthetics known as viscous lidocaine, the U.S. Food and Drug Administration (FDA) recently reported. When used among infants and young children, such medications can… Read More
By Simmons Hanly Conroy | June 27, 2014
Pharmaceutical News Wrap Up: June 2014
The Firm pharmaceutical lawyers are dedicated to providing you with the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls, approvals and warning… Read More
By Simmons Hanly Conroy | June 23, 2014
New Risk of Blood Clots Associated with Testosterone Treatments
The US Food and Drug Administration (FDA), announced last week that there has been another risk associated with testosterone treatments. The FDA is now requiring manufacturers of testosterone or low T products must… Read More
By Simmons Hanly Conroy | June 11, 2014
Testosterone Therapy Lawsuits Consolidated Before One Judge
The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More
By Simmons Hanly Conroy | June 10, 2014
Testosterone Therapy Lawsuits Consolidated Before One Judge
The U.S. Judicial Panel on Multidistrict Litigation has ordered the consolidation of all federal testosterone therapy lawsuits before the Hon. Matthew F. Kennelly in the Northern District of Illinois, U.S. District Court.… Read More
By Simmons Hanly Conroy | May 9, 2014
Older Americans Month and Mesothelioma: Safe Today, Healthy Tomorrow
Between 1999 and 2005, 67 percent of the Americans diagnosed with mesothelioma were older than age 65, according to the Centers for Disease Control. Mesothelioma, a rare cancer caused by asbestos exposure,… Read More
By Simmons Hanly Conroy | May 7, 2014
FDA Moves Transvaginal Mesh Devices to ‘High Risk’ Category
The U.S. Food and Drug Administration recently submitted a federal proposal to establish stricter safety requirements for transvaginal surgical mesh implants. The devices are often used to repair pelvic collapse in women, and… Read More
By Simmons Hanly Conroy | April 28, 2014
Keep Fighting: A Tribute to Bob Guinn, Mesothelioma Warrior
My friend, Bob Guinn, passed away this morning from mesothelioma. Bob was my client. Over the past four years, he fought against this rare cancer caused by asbestos. He courageously shared his… Read More
By Simmons Hanly Conroy | April 22, 2014
Pharmaceutical News Wrap Up: April 2014
Here at the Firm, our pharmaceutical lawyers are committed to keeping you on track with the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning… Read More
